Biomarkers Market PPT 2024: Size, Growth, Demand and Forecast till 2032

1
Global Biomarkers Market Research and Forecast
Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Biomarkers Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global biomarkers market
  size reached US 79.9 Billion in 2023.
• A biomarker is a measurable indicator of some
  biological state or condition, often used for the
  assessment of physiological and pathological
  processes, as well as pharmacological responses
  to therapeutic interventions. Biomarkers can be
  found in various biological specimens such as
  blood, urine, saliva, and tissue. They are
  instrumental in diagnosing diseases, monitoring
  disease progression, and evaluating the
  effectiveness of treatments.
• The manufacturing process of biomarkers involves
  a sequence of intricate steps, from discovery to
  validation. Initially, a potential biomarker is
  identified through research often involving
  high-throughput techniques, such as mass
  spectrometry or gene sequencing. Post-discovery,
  the biomarker undergoes rigorous clinical trials
  to verify its efficacy and safety.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/biomarkers-market/reque
  stsample

4
Report Description

• Global Biomarkers Market Trends
• The global market is primarily driven by the
  growing prevalence of chronic diseases such as
  cancer, cardiovascular diseases, and
  neurodegenerative disorders, which necessitates
  early and accurate diagnosis for effective
  treatment. The escalation in research funding and
  investment in healthcare infrastructure is
  another significant booster for the market.
  Advances in genomics, proteomics, and
  bioinformatics are paving the way for the
  discovery of novel biomarkers, thus expanding
  their applications. Furthermore, technological
  advancements in medical imaging, biosensors, and
  lab-on-chip devices are enhancing the detection
  capabilities of biomarkers. Collaborations
  between pharmaceutical companies and research
  institutions are fostering innovation and
  expediting the commercialization process.
• The rise in personalized medicine and the advent
  of minimally invasive biomarker technologies are
  additional trends shaping the market landscape.
  Regulatory support and the increasing focus on
  patient-centric approaches are also serving as
  catalysts for market growth. Other factors,
  including rapid urbanization and extensive
  research and development (RD) activities
  conducted by key players, are also positively
  influencing the market.
• Looking forward, the market value is projected to
  reach US 220.7 Billion by 2032, expanding at a
  CAGR of 11.37 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/biomarkers-market

5
Report Segmentation

• Breakup by Product
• Consumables
• Services
• Software
•  
• Breakup by Type
• Efficacy Biomarkers
• Safety Biomarkers
• Validation Biomarkers
• Breakup by Disease
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Immunological Disorders

6
Report Segmentation

• Renal Disorders
• Others
• Breakup by Application
• Diagnostics
• Drug Discovery and Development
• Personalized Medicine
• Others
• Breakup by End User
• Pharmaceutical and Biotechnology Companies
• Diagnostic and Research Laboratories
• Hospitals and Specialty Clinics
• Others

7
Report Segmentation

• Breakup by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Charles River Laboratories International Inc.
• Epigenomics AG
• Eurofins Scientific SE
• Merck KGaA
• Perkinelmer Inc.
• Qiagen N.V
• Quanterix Corporation
• SphingoTec GmbH
• Thermo Fisher Scientific Inc.

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
11
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Biomarkers Market   
  5.1    Market Overview    5.2    Market
  Performance    5.3    Impact of COVID-19  5.4
     Market Forecast
• 6     Market Breakup by Product    6.1  
   Consumables        6.1.1 Market Trends       
  6.1.2 Market Forecast    6.2    Services       
  6.2.1 Market Trends        6.2.2 Market
  Forecast    6.3    Software        6.3.1 Market
  Trends        6.3.2 Market Forecast7   Market
  Breakup by Type       

12
Table of Contents

•     7.1    Efficacy Biomarkers        7.1.1
  Market Trends        7.1.2 Market Forecast   
  7.2    Safety Biomarkers        7.2.1 Market
  Trends        7.2.2 Market Forecast    7.3  
   Validation Biomarkers        7.3.1 Market
  Trends        7.3.2 Market Forecast8   Market
  Breakup by Disease    8.1    Cancer       
  8.1.1 Market Trends        8.1.2 Market
  Forecast    8.2    Cardiovascular Disorders   
      8.2.1 Market Trends        8.2.2 Market
  Forecast    8.3    Neurological Disorders     
    8.3.1 Market Trends        8.3.2 Market
  Forecast    8.4    Immunological Disorders     
    8.4.1 Market Trends        8.4.2 Market
  Forecast
•     8.5    Renal Disorders        8.5.1 Market
  Trends        8.5.2 Market Forecast
•     8.6    Others        8.6.1 Market Trends   
      8.6.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/biomarkers-market/toc

13
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com